Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 810	$ 615
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(122)	(41)
Purchases of property and equipment	(561)	(696)
Proceeds from disposition of hospitals and other ancillary operations	12	87
Proceeds from sale of property and equipment	10	13
Purchases of available-for-sale securities	(395)	(127)
Proceeds from sales of available-for-sale securities	386	123
Proceeds from sale of investments in unconsolidated affiliates	403
Distribution from Quorum Health Corporation	1,219
Increase in other investments	(201)	(136)
Net cash provided by (used in) investing activities	751	(777)
Cash flows from financing activities:
Proceeds from exercise of stock options		24
Repurchase of restricted stock shares for payroll tax withholding requirements	(5)	(20)
Deferred financing costs and other debt-related costs	(22)	(30)
Redemption of noncontrolling investments in joint ventures	(19)	(18)
Distributions to noncontrolling investors in joint ventures	(69)	(69)
Borrowings under credit agreements	3,929	3,464
Proceeds from receivables facility	66	112
Repayments of long-term indebtedness	(5,492)	(3,624)
Net cash used in financing activities	(1,612)	(161)
Net change in cash and cash equivalents	(51)	(323)
Cash and cash equivalents at beginning of period	184	509
Cash and cash equivalents at end of period	133	186
Parent Company [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(13)	(14)
Cash flows from financing activities:
Proceeds from exercise of stock options		24
Repurchase of restricted stock shares for payroll tax withholding requirements	(5)	(20)
Changes in intercompany balances with affiliates, net	18	10
Net cash used in financing activities	13	14
Issuer [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(322)	(220)
Cash flows from investing activities:
Distribution from Quorum Health Corporation	1,219
Net cash provided by (used in) investing activities	1,219
Cash flows from financing activities:
Deferred financing costs and other debt-related costs	(22)	(30)
Changes in intercompany balances with affiliates, net	530	260
Borrowings under credit agreements	3,905	3,220
Repayments of long-term indebtedness	(5,310)	(3,230)
Net cash used in financing activities	(897)	220
Other Guarantor [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	742	309
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(3)	(20)
Purchases of property and equipment	(386)	(466)
Proceeds from disposition of hospitals and other ancillary operations	13	20
Proceeds from sale of property and equipment	6	6
Purchases of available-for-sale securities	(171)	(42)
Proceeds from sales of available-for-sale securities	157	38
Proceeds from sale of investments in unconsolidated affiliates	403
Increase in other investments	(149)	(76)
Net cash provided by (used in) investing activities	(130)	(540)
Cash flows from financing activities:
Changes in intercompany balances with affiliates, net	(597)	(100)
Borrowings under credit agreements	23	30
Repayments of long-term indebtedness	(52)	(44)
Net cash used in financing activities	(626)	(114)
Net change in cash and cash equivalents	(14)	(345)
Cash and cash equivalents at beginning of period	32	373
Cash and cash equivalents at end of period	18	28
Non-Guarantor Subsidiaries [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	403	540
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(119)	(21)
Purchases of property and equipment	(175)	(230)
Proceeds from disposition of hospitals and other ancillary operations	(1)	67
Proceeds from sale of property and equipment	4	7
Purchases of available-for-sale securities	(224)	(85)
Proceeds from sales of available-for-sale securities	229	85
Increase in other investments	(52)	(60)
Net cash provided by (used in) investing activities	(338)	(237)
Cash flows from financing activities:
Redemption of noncontrolling investments in joint ventures	(19)	(18)
Distributions to noncontrolling investors in joint ventures	(69)	(69)
Changes in intercompany balances with affiliates, net	49	(170)
Borrowings under credit agreements	1	214
Proceeds from receivables facility	66	112
Repayments of long-term indebtedness	(130)	(350)
Net cash used in financing activities	(102)	(281)
Net change in cash and cash equivalents	(37)	22
Cash and cash equivalents at beginning of period	152	136
Cash and cash equivalents at end of period	$ 115	$ 158